Immune responses to hepatitis B vaccination after hematopoietic stem cell transplantation in pediatric and young adult patients.

Krittiya ChaichotjindaUsanarat AnurathapanSophida BoonsathornSujittra ChaisavaneeyakornSuporn TreepongkarunaChonnamet TechasaensiriNopporn Apiwattanakul

Published in: Clinical transplantation (2020)

In the current study the anti-HBs seroconversion rate after three HBV revaccinations was excellent. CMV reactivation, anti-HBs seronegativity before HSCT, and three DTwP-HBV-Hib revaccinations were associated with non-seroconversion, but the non-responder rate was low.

Keyphrases

hepatitis b virus
immune response
end stage renal disease
young adults
ejection fraction
newly diagnosed
chronic kidney disease
liver failure
acute myeloid leukemia
patient reported outcomes
dendritic cells
childhood cancer